Literature DB >> 12885941

Expression of L-CCR in HEK 293 cells reveals functional responses to CCL2, CCL5, CCL7, and CCL8.

Knut Biber1, Mike W Zuurman, Han Homan, Hendrikus W G M Boddeke.   

Abstract

It has become clear in the past years that chemokines and chemokine receptors are pivotal regulators of cellular communication and trafficking. In addition to the approximately 20 chemokine receptors that have been cloned and described, various orphan receptors with a chemokine receptor-like structure are known. We have investigated the orphan mouse chemokine receptor (L-CCR) in HEK 293 cells, a receptor that was originally described in a mouse macrophage cell line. Cells expressing this receptor show pertussis toxin-sensitive chemotaxis and small intracellular calcium transients in response to the chemokines CCL2, CCL7, CCL8, and CCL5. Biotinylated CCL2 binds to L-CCR-expressing cells, and transfection experiments with an L-CCR-green fluorescent protein fusion protein showed L-CCR expression in the membranes of recombinant HEK 293 cells. Although radioligand binding was not detected, it is suggested that L-CCR is a functional chemokine receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885941     DOI: 10.1189/jlb.0802415

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  25 in total

1.  Microarray analysis of Aeromonas hydrophila cytotoxic enterotoxin-treated murine primary macrophages.

Authors:  C L Galindo; A A Fadl; J Sha; A K Chopra
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Authors:  Lei-Ping Wang; Jun Cao; Jian Zhang; Bi-Yun Wang; Xi-Chun Hu; Zhi-Min Shao; Zhong-Hua Wang; Zhou-Luo Ou
Journal:  Med Oncol       Date:  2015-10-20       Impact factor: 3.064

Review 3.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

4.  CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS.

Authors:  Maria Rosito; Cristina Deflorio; Cristina Limatola; Flavia Trettel
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

Review 5.  Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.

Authors:  Teizo Yoshimura; Joost J Oppenheim
Journal:  Exp Cell Res       Date:  2010-11-04       Impact factor: 3.905

6.  Mouse MCP1 C-terminus inhibits human MCP1-induced chemotaxis and BBB compromise.

Authors:  Yao Yao; Stella E Tsirka
Journal:  J Neurochem       Date:  2011-06-13       Impact factor: 5.372

7.  Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion.

Authors:  Fletcher A White; Jihu Sun; Stephen M Waters; Chao Ma; Dongjun Ren; Matthew Ripsch; Jeremy Steflik; Daniel N Cortright; Robert H Lamotte; Richard J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-20       Impact factor: 11.205

8.  Nonredundant role of CCRL2 in lung dendritic cell trafficking.

Authors:  Karel Otero; Annunciata Vecchi; Emilio Hirsch; Jennifer Kearley; William Vermi; Annalisa Del Prete; Safiyè Gonzalvo-Feo; Cecilia Garlanda; Ornella Azzolino; Laura Salogni; Clare M Lloyd; Fabio Facchetti; Alberto Mantovani; Silvano Sozzani
Journal:  Blood       Date:  2010-07-06       Impact factor: 22.113

9.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

10.  Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner.

Authors:  Tanja N Hartmann; Marion Leick; Susann Ewers; Andrea Diefenbacher; Ingrid Schraufstatter; Marek Honczarenko; Meike Burger
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.